$LFST

Yawaog Enterprises Corp (LFST) insider to sell 7,500 vested shares under Rule 144

Yawaog Enterprises Corp (LFST) disclosed via a Rule 144 filing that an insider plans to sell 7,500 vested common shares through Fidelity Brokerage Services LLC on NASDAQ. The filing cites an indicated aggregate market value of $95,118.49 as of the proposed transaction. It also references prior sales of 20,441 shares on Aug. 13, 2026 for $249,993.43.

Original reporting
Published Aug 14, 2026, 7:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 11:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$LFST
Neutral
medium confidence
Mentioned
$LFST
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$LFSTNeutralLow
01

Why it matters

The disclosure mainly informs positioning around potential incremental share supply from insider liquidity. It does not provide new operating, financial, or regulatory information about LFST.

02

Market read

For LFST traders, the actionable takeaway is potential near-term selling pressure from an insider’s planned Rule 144 transaction, with no fundamental catalyst mentioned.

03

What to watch

Traders should check whether additional Form 144/insider transactions follow soon after, which could compound supply effects beyond this single planned sale.

Relevance 4/10Novelty 3/10Timing: Rule 144 planned sale disclosed for near-term execution after filing.

Background

The article summarizes a planned insider sale of LFST common stock under SEC Rule 144, including the vesting origin and prior sales in the last three months.

Company-level read

Ticker impact

$LFSTNeutralMedium confidence
Context

LFST insider plans to sell 7,500 vested shares under Rule 144 via Fidelity, with indicated value of $95,118.49.

Expected impact

Low likelihood of a sustained move; any impact is likely short-lived unless follow-on sales expand.

Evidence & confidence

The filing is a planned Rule 144 sale of a relatively small block versus prior 3-month sales, with no accompanying fundamental change disclosed.

Market effects

Minimal, as this is company-specific insider selling with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

Insider selling under Rule 144 can be pre-scheduled for diversification or tax needs and may not reflect negative fundamentals.

Key entities

  • Yawaog Enterprises Corp

    Subject of the Rule 144 planned insider sale of 7,500 vested shares.

  • Fidelity Brokerage Services LLC

    Broker through which the planned sale is intended to be executed.

Related articles

$LFSTMedAI 8/10

LifeStance Health Group, Inc. Q2 2026 Earnings Call Summary

LifeStance Health Group reported Q2 2026 revenue growth of 26%, driven by higher visit volumes and a 6% rise in revenue per visit, and said visits per clinician rose 7% YoY. The company raised full-year 2026 guidance to $1.685B-$1.725B revenue and 13.2% adjusted EBITDA margins, approved a new $100M buyback, and reported Q2 free cash flow of $88M.

$LFSTHighAI 9/10

LifeStance (LFST) Q2 2026 Earnings Call Transcript

LifeStance (LFST) reported Q2 2026 results on an earnings call. Revenue rose to $435 million (+26%) on 2.6 million visits (+19%) and total revenue per visit of $167 (+6%). Adjusted EBITDA was $66 million (+94%) with a 15.2% margin. Full-year 2026 revenue guidance was raised to $1.685-$1.725 billion and adjusted EBITDA to $215-$235 million.